A groundbreaking new treatment using gene therapy is giving hope to patients who endure sickle cell disease. Sickle cell anemia is a genetic blood condition that can cause debilitating pain. Patients often rely on bone marrow donors to help manage their disease. But a new type of treatment that uses the gene editing technology known as CRISPR, is being described as a "game changer." "It was like one of those moments where like, you're running. Almost like a marathon runner, and you make it to one of those checkpoints that matter," said KD Hall. Read more: https://www.king5.com/article/news/health/fda-approves-gene-editing-technology-sickle-cell-disease-healthlink/281-e7700ee9-ff1b-4dcd-9826-096e59410a00